Immunotherapy has revolutionized cancer care, but it brings a unique set of challenges. Unlike chemotherapy, which attacks rapidly dividing cells, immunotherapy "wakes up" the immune system. Occasionally, this supercharged immune response can mistakenly target healthy organs, leading to "Immune-Related Adverse Events" (irAEs).

In 2026, the key to successful treatment is early detection and rapid management. At Onco Medicine, we emphasize that most side effects are highly treatable if caught early, allowing patients to continue their journey toward remission.

Common irAEs and Management Strategies

• Skin Rash & Inflammation: Often the first sign, usually managed with topical or oral corticosteroids.
• Gastrointestinal Issues (Colitis): Early symptoms like diarrhea should be reported immediately to prevent severe bowel inflammation.
• Endocrine Changes: Immunotherapy can affect the thyroid or pituitary glands, requiring simple hormonal replacement therapy.
• Respiratory Symptoms (Pneumonitis): Rare but serious; reported shortness of breath is a priority for clinical teams.

Communication is your strongest tool. By maintaining a "Symptom Journal" and staying in constant contact with your oncology team, you can navigate these challenges safely. Onco Medicine is your partner in ensuring that your treatment is as smooth and effective as possible.